Kenneth Rainin Foundation
Overview
Kenneth Rainin Foundation is a private foundation that provides grantmaking and philanthropic support, including program-related investments, to advance research in inflammatory bowel disease, early childhood literacy, and the arts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| G-Tech Medical | May 2020 | Series A | Co-investor |
| Thetis Pharmaceuticals | Jul 2021 | Grant | Lead |
Key People
Jennifer Rainin
CEO
Shelley Trott
Executive Director
Amanda Flores-Witte
Communications Director (June 2017 to present) Sr Comms Ofcr 2015-2017 Comms Ofcr 2013-2015
Dana Cilono
Director of Education Strategy and Ventures
Laura Wilson
Director of Health Strategy & Ventures
Liz O'Malley
Director, Arts Strategy & Ventures
Richard McConnell
Director Of Information Technology
Miyesha Perry
Chief Program Officer
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kenneth Rainin Foundation based?
Kenneth Rainin Foundation is headquartered in Oakland, California, United States.
When was Kenneth Rainin Foundation founded?
Kenneth Rainin Foundation was founded in 2009.
How many portfolio companies does Kenneth Rainin Foundation have?
Kenneth Rainin Foundation has 2 portfolio companies in Caplight's dataset.
What are some companies in Kenneth Rainin Foundation's portfolio?
Portfolio companies visible on Caplight include G-Tech Medical, Thetis Pharmaceuticals.
What was Kenneth Rainin Foundation's most recent investment shown here?
Kenneth Rainin Foundation's most recent investment in this portfolio sample was in Thetis Pharmaceuticals in 2021.
What sectors does Kenneth Rainin Foundation focus on?
Kenneth Rainin Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Kenneth Rainin Foundation focus on?
Stage focus information for Kenneth Rainin Foundation is not publicly available.